Compare Ascendis Pharma A/S (ASND) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Prologis Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Prologis Inc trades at $139.28 (market cap $132.57B). The key difference: Prologis Inc is far larger — about 8× Ascendis Pharma A/S's market cap, and Prologis Inc pays a 3.07% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | PLD | |
|---|---|---|
Market Cap | $16.67B | $132.57B |
Sector | Health | Real Estate |
52-Week High | $277.18 | $149.96 |
52-Week Low | $189.74 | $104.81 |
Enterprise Value | $17.04B | $167.31B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
